Google
 
Google

World Stem Cell Summit 2010

Friday, June 13, 2008

British Journal of Cancer - Table of Contents alert Volume 98 Issue 12

Sponsored By Agilent Cancer Research

High Denisty Mircroarray Scanning

Agilent's new High-Resolution Scanner delivers fast, sharp scans of
today's microarrays, with enough resolution for tomorrow's
high-density applications. With 20x greater dynamic range than other
scanners, you'll always get the whole picture.

Buy now and take 10% off your scanner price when purchased with
Agilent microarrays.

http://ealerts.nature.com/cgi-bin24/DM/y/elTj0Xztnp0Hhi0BxRb0EO


British Journal of Cancer
10 June 2008, Volume 98, Issue 12
Table of Contents

Reviews

1881 Proteins that bind methylated DNA and human cancer: reading the
wrong words

L Lopez-Serra and M Esteller

http://ealerts.nature.com/cgi-bin24/DM/y/elTj0Xztnp0Hhi0BxRc0EP
_____________________________________________________________________

1886 Tumour-stroma interactions in colorectal cancer: converging on
beta-catenin activation and cancer stemness

N H Le, P Franken and R Fodde

http://ealerts.nature.com/cgi-bin24/DM/y/elTj0Xztnp0Hhi0BxRd0EQ
_____________________________________________________________________

Clinical Studies

1894 Evidence-based pragmatic guidelines for the follow-up of
testicular cancer: optimising the detection of relapse

N J van As, D C Gilbert, J Money-Kyrle, D Bloomfield, S
Beesley, D P Dearnaley, A Horwich and R A Huddart

http://ealerts.nature.com/cgi-bin24/DM/y/elTj0Xztnp0Hhi0BxRe0ER
_____________________________________________________________________

1903 Supportive care needs of men living with prostate cancer in
England: a survey

E Ream, A Quennell, L Fincham, S Faithfull, V Khoo, J
Wilson-Barnett and A Richardson

http://ealerts.nature.com/cgi-bin24/DM/y/elTj0Xztnp0Hhi0BxRf0ES
_____________________________________________________________________

1910 Prognostic role of topoisomerase-IIalpha in advanced ovarian
cancer patients

G Ferrandina, M Petrillo, A Carbone, G Zannoni, E
Martinelli, M Prisco, S Pignata, E Breda, A Savarese and G
Scambia

http://ealerts.nature.com/cgi-bin24/DM/y/elTj0Xztnp0Hhi0BxRg0ET
_____________________________________________________________________

1916 Pegylated liposomal doxorubicin and gemcitabine in the
front-line treatment of recurrent/metastatic breast
cancer: a multicentre phase II study

V Adamo, V Lorusso, R Rossello, B Adamo, G Ferraro, D
Lorusso, G Condemi, D Priolo, L Di Lullo, A Paglia, S
Pisconti, G Scambia and G Ferrandina

http://ealerts.nature.com/cgi-bin24/DM/y/elTj0Xztnp0Hhi0BxRh0EU
_____________________________________________________________________

1922 The influence of sentinel lymph node tumour burden on
additional lymph node involvement and disease-free
survival in cutaneous melanoma - a retrospective analysis
of 392 cases

M Guggenheim, R Dummer, F J Jung, D Mihic-Probst, H
Steinert, V Rousson, L E French and P Giovanoli

http://ealerts.nature.com/cgi-bin24/DM/y/elTj0Xztnp0Hhi0BxRi0EV
_____________________________________________________________________

1929 Cancer risk in patients with constitutional chromosome
deletions: a nationwide British cohort study

A J Swerdlow, M J Schoemaker, C D Higgins, A F Wright and
P A Jacobs

http://ealerts.nature.com/cgi-bin24/DM/y/elTj0Xztnp0Hhi0BxRj0EW
_____________________________________________________________________

1934 Are one or two simple questions sufficient to detect depression
in cancer and palliative care? A Bayesian meta-analysis

A J Mitchell

http://ealerts.nature.com/cgi-bin24/DM/y/elTj0Xztnp0Hhi0BxRk0EX
_____________________________________________________________________

1944 The impact of cancer research: how publications influence UK
cancer clinical guidelines

G Lewison and R Sullivan

http://ealerts.nature.com/cgi-bin24/DM/y/elTj0Xztnp0Hhi0BxRl0EY
_____________________________________________________________________

Translational Therapeutics

1951 Phase I pharmacokinetic and pharmacodynamic study of the prenyl
transferase inhibitor AZD3409 in patients with advanced
cancer

N M G M Appels, M J Bolijn, K Chan, T C Stephens, G
Hoctin-Boes, M Middleton, J H Beijnen, J S de Bono, A L
Harris and J H M Schellens

http://ealerts.nature.com/cgi-bin24/DM/y/elTj0Xztnp0Hhi0BxRm0EZ
_____________________________________________________________________

1959 Oxaliplatin-DNA adduct formation in white blood cells of cancer
patients

A C Pieck, A Drescher, K G Wiesmann, J Messerschmidt, G
Weber, D Strumberg, R A Hilger, M E Scheulen and U Jaehde

http://ealerts.nature.com/cgi-bin24/DM/y/elTj0Xztnp0Hhi0BxRn0Ea
_____________________________________________________________________

1966 Antitumour and antiangiogenic effects of Aplidin® in the 5TMM
syngeneic models of multiple myeloma

J Caers, E Menu, H De Raeve, D Lepage, E Van Valckenborgh,
B Van Camp, E Alvarez and K Vanderkerken

http://ealerts.nature.com/cgi-bin24/DM/y/elTj0Xztnp0Hhi0BxRo0Eb
_____________________________________________________________________

Molecular Diagnostics

1975 PDK-1 regulates lactate production in hypoxia and is associated
with poor prognosis in head and neck squamous cancer

S M Wigfield, S C Winter, A Giatromanolaki, J Taylor, M L
Koukourakis and A L Harris

http://ealerts.nature.com/cgi-bin24/DM/y/elTj0Xztnp0Hhi0BxRp0Ec
_____________________________________________________________________

1985 Oesophageal adenocarcinoma is associated with a deregulation in
the MYC/MAX/MAD network

J K R Boult, P Tanière, M T Hallissey, M J Campbell and C
Tselepis

http://ealerts.nature.com/cgi-bin24/DM/y/elTj0Xztnp0Hhi0BxRq0Ed
_____________________________________________________________________

1993 Prognostic impact of syndecan-1 expression in invasive ductal
breast carcinomas

D Loussouarn, L Campion, C Sagan, J-S Frenel, F Dravet,
J-M Classe, R Pioud-Martigny, D Berton-Rigaud, E
Bourbouloux, J-F Mosnier, F-R Bataille and M Campone

http://ealerts.nature.com/cgi-bin24/DM/y/elTj0Xztnp0Hhi0BxRr0Ee
_____________________________________________________________________

1999 beta2microglobulin mRNA expression levels are prognostic for
lymph node metastasis in colorectal cancer patients

J Shrout, M Yousefzadeh, A Dodd, K Kirven, C Blum, A
Graham, K Benjamin, R Hoda, M Krishna, M Romano, M
Wallace, E Garrett-Mayer and M Mitas

http://ealerts.nature.com/cgi-bin24/DM/y/elTj0Xztnp0Hhi0BxRs0Ef
_____________________________________________________________________

Genetics and Genomics

2006 Glutathione-S-transferase M1, T1 and P1 polymorphisms, and
breast cancer risk, in BRCA1/2 mutation carriers

L Kadouri, Z Kote-Jarai, A Hubert, M Baras, D Abeliovich,
T Hamburger, T Peretz and R A Eeles

http://ealerts.nature.com/cgi-bin24/DM/y/elTj0Xztnp0Hhi0BxRt0Eg
_____________________________________________________________________

Letters to the Editor

2011 Early onset of breast cancer in British black women

A Cichowska, C M Fischbacher, A Brock, C Griffiths, R
Bhopal and S H Wild

http://ealerts.nature.com/cgi-bin24/DM/y/elTj0Xztnp0Hhi0BxRu0Eh
_____________________________________________________________________

2012 Reply: Early onset of breast cancer in British black women

R L Bowen, S W Duffy, D A Ryan, I R Hart and J L Jones

http://ealerts.nature.com/cgi-bin24/DM/y/elTj0Xztnp0Hhi0BxRv0Ei
_____________________________________________________________________

Corrigenda

2013 Proteomic analysis of stage I primary lung adenocarcinoma aimed
at individualization of postoperative therapy

J Maeda, T Hirano, A Ogiwara, S Akimoto, T Kawakami, Y
Fukui, T Oka, Y Gong, R Guo, H Inada, K Nawa, M Kojika, Y
Suga, T Ohira, K Mukai and H Kato

http://ealerts.nature.com/cgi-bin24/DM/y/elTj0Xztnp0Hhi0BxRw0Ej
_____________________________________________________________________

2015 The BOADICEA model of genetic susceptibility to breast and
ovarian cancers: updates and extensions

A C Antoniou, A P Cunningham, J Peto, D G Evans, F Lalloo,
S A Narod, H A Risch, J E Eyfjord, J L Hopper, M C
Southey, H Olsson, O Johannsson, A Borg, B Pasini, P
Radice, S Manoukian, D M Eccles, N Tang, E Olah, H
Anton-Culver, E Warner, J Lubinski, J Gronwald, B Gorski,
L Tryggvadottir, K Syrjakoski, O-P Kallioniemi, H Eerola,
H Nevanlinna, P D P Pharoah and D F Easton

http://ealerts.nature.com/cgi-bin24/DM/y/elTj0Xztnp0Hhi0BxRx0Ek
_____________________________________________________________________

2016 Author Index for Volume 98

http://ealerts.nature.com/cgi-bin24/DM/y/elTj0Xztnp0Hhi0BxRy0El
_____________________________________________________________________

2025 Keyword Index for Volume 98

http://ealerts.nature.com/cgi-bin24/DM/y/elTj0Xztnp0Hhi0BxRz0Em
_____________________________________________________________________


======================================================================

You have been sent this Table of Contents Alert because you have opted in to receive it.
You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at:
http://www.nature.com/myaccount
(You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department:
registration@nature.com

For print subscription enquiries, please contact our subscription department:
subscriptions@nature.com

For other enquiries, please contact customer feedback department:
feedback@nature.com

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne -
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and
Wales under company number 785998 and whose registered office is located
at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

(c) Copyright 2008 Nature Publishing Group

======================================================================

Google

Any Comments ?.......

E-mail: manojhind2001us@gmail.com
Google
 

World Time